3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Infections - Tuberculosis -

UK immigrant screening misses most latent TB: study

Infections • • TuberculosisApr 21, 11

British tuberculosis screening for new immigrants fails to detect most imported cases of latent disease and screening should be widened to include more people from the Indian subcontinent, scientists said on Thursday.

Britain has recently been dubbed “the tuberculosis (TB) capital of Europe” and is the only country in Western Europe with rising rates of disease.

Current British border policies require immigrants from countries with a TB incidence higher than 40 per 100,000 people to have a chest X-ray on arrival to check for active TB.

This generally covers African countries but excludes places in Asia such as India, Pakistan and Bangladesh.

TB is caused by a bacterial infection which is normally asymptomatic, but about one in 10 cases lead to active disease which attacks the lungs and kills around half of those affected.

While very few immigrants have active TB on arrival, many of them are carriers of the latent disease, which often progresses to active TB within a few years of their arrival in Britain.

To see whether the screening was effective, British researchers analyzed demographic and test result data from 2008 to 2010 at three immigrant screening centers in Britain using a highly specific blood test for detecting latent tuberculosis, called an interferon-gamma release assay (IGRA).

Their results, published in The Lancet Infectious Diseases journal, showed 20 percent of recent immigrants from the Indian sub-continent and almost 30 percent from sub-Saharan Africa are carriers of latent TB.

This means the current screening policy, which excludes immigrants from the Indian subcontinent, has been missing 70 percent of imported latent TB, they said.

TB is a worldwide pandemic. Among the 15 countries with the highest estimated TB incidence rates, 13 are in Africa, while a third of all new cases are in India and China, according to the World Health Organization (WHO).

The WHO also says drug-resistant TB is rapidly increasing around the world and these often fatal strains of the disease are expected to affect two million people by 2050.

COST EFFECTIVE

Britain has more than 9,000 cases of TB diagnosed a year and the problem is becoming particularly acute in the capital, which experts say accounts for 40 percent of the nation’s total diagnosed cases.

In this study, the researchers also assessed how cost-effective it would be to lower the threshold so people from more countries are screened. They found including immigrants from the Indian subcontinent would detect over 90 percent of latent TB cases, and would cost little more than now.

“By changing the threshold for screening, and including immigrants from the Indian subcontinent, we could pick up 92 percent of imported latent TB,” said Ajit Lalvan from Imperial College London, who led the study.

“By treating people at that early stage, we can prevent them from developing a serious illness and becoming infectious.”

The national incidence of TB has risen dramatically over the last decade, increasing by almost 50 percent between 1998 and 2009. Much of this increase has been driven by a 98 percent increase in cases among immigrants.

Foreign-born people account for nearly three quarters of the country’s TB cases, and have a 20 times higher incidence of TB than people born in Britain.

###

By Kate Kelland

LONDON



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  Many European countries ill-prepared to prevent and control the spread of viral hepatitis
  HPV vaccination not associated with increase in sexually transmitted infections
  Hepatitis C more prevalent than HIV/AIDS or Ebola yet lacks equal attention
  To curb hepatitis C, test and treat inmates
  Vinegar kills tuberculosis and other mycobacteria
  New strategy emerges for fighting drug-resistant malaria
  Toys, books, cribs harbor bacteria for long periods, study finds
  California high school to test students for tuberculosis
  TB Vaccine May Work Against Multiple Sclerosis
  Tuberculosis: Nature has a double-duty antibiotic up her sleeve
  Treatment target identified for a public health risk parasite
  Nearly half of U.S. children late receiving vaccines

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site